Quantcast

Latest unstable angina Stories

2014-10-12 23:00:34

MarketOptimizer.org adds “Unstable Angina Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Unstable Angina. Dallas, TX (PRWEB) October 13, 2014 Unstable angina is angina pectoris caused by disruption of an atherosclerotic plaque with partial thrombosis and possibly embolization or vasospasm. It is characterized by at least one of the following: Occurs at rest or minimal exertion and usually...

2014-07-14 23:02:45

ReportsnReports.com adds “EpiCast Report Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2022” to its store. The majority of the cases occurred in men (58.15%) and in those ages 65 years (69.34%). Dallas, TX (PRWEB) July 14, 2014 Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ACS incidence increases with age and will...

2014-01-15 23:21:52

MarketOptimizer.org adds Latest Report on “EpiCast Report: Acute Coronary Syndrome (ACS) – Epidemiology Forecast to 2022” to its store. Dallas, TX (PRWEB) January 15, 2014 Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ACS incidence increases with age and will be a significant public health problem as the elderly population...

2011-11-14 22:28:32

BIDMC researcher says improvement in survival rates best 'since introduction of aspirin' An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions. The results were also published online by the New England Journal of Medicine. The drug, rivaroxaban, proved effective in preventing the...

2011-10-11 18:04:16

Fewer deaths and myocardial infarctions in unstable angina pectoris and NSTEMI / AMNOG procedure has passed the first practical test Since the start of 2011, the active ingredient ticagrelor can be prescribed in Germany in addition to acetylsalicylic acid (ASA) to avoid blood clots in patients with acute ischaemia of the cardiac muscle. The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined whether ticagrelor offers advantages to patients with acute...

2011-07-06 00:06:09

In an examination of the appropriateness of the widespread use of percutaneous coronary interventions (PCIs), researchers found that of more than 500,000 PCIs included in the study, nearly all for acute indications were classified as appropriate, whereas only about half of PCIs performed for nonacute indications could be classified as appropriate, according to a study in the July 6 issue of JAMA. "Approximated 600,000 percutaneous coronary interventions [procedures such as balloon angioplasty...

2011-04-07 15:39:22

New guidelines for the management of patients with unstable angina and non-ST-elevation myocardial infarction (termed acute coronary syndromes) have been released by the American College of Cardiology and the American Heart Association. The guidelines were created by a consortium of national experts including a cardiologist from Baylor College of Medicine. "This important document is an update of the 2007 ACC/AHA guidelines. We examined past recommendations, reviewed the clinical data that...

2011-03-29 12:34:00

PARSIPPANY, N.J. and INDIANAPOLIS, March 29, 2011 /PRNewswire/ -- Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients undergoing percutaneous coronary intervention (PCI) after experiencing heart-related chest pain at rest (unstable angina) or non-ST segment elevation myocardial infarction (NSTEMI). NSTEMI is a type of heart attack that that does not need to be...

2009-08-31 07:00:00

BARCELONA, Spain, Aug. 31 /PRNewswire/ -- A new analysis from the JUPITER study showed that CRESTOR((R)) (rosuvastatin calcium) 20mg reduced the composite primary end point of major cardiovascular (CV) events (myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by 39% (p<0.001), compared to placebo, in elderly patients with LDL-C less than 130 mg/dL and elevated high-sensitivity C-reactive protein (hsCRP). This analysis...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.